v3.26.1
Condensed Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenues $ 12,074 $ 5,661
Cost of goods sold 2,133 1,015
Gross Profit 9,941 4,646
Operating expenses    
Research and Development Expense 1,692 1,354
Selling, General and Administrative Expense 25,186 13,596
Total operating expenses 26,878 14,950
Loss from operations (16,937) (10,304)
Other income (expense)    
Change in fair value of convertible notes payable (728) (0)
Interest expense (357) (239)
Other income (expense), net 282 (109)
Total other expense, net (803) (348)
Loss before provision for income tax (17,740) (10,652)
Provision for income tax 0 (1)
Net loss attributable to common stockholders $ (17,740) $ (10,653)
Net loss per share attributable to common stockholders    
Basic (in dollars per share) $ (19.3) $ (12.97)
Diluted (in dollars per share) $ (19.3) $ (12.97)
Share (denominator):    
Weighted average number of common shares outstanding used in basic computation 918,935 821,160
Shares used in diluted computation 918,935 821,160